A U.S. appeals court on Tuesday said it will accelerate reviewing Illumina Inc s challenge to a federal agency order requiring the biotechnology company to divest cancer diagnostic test maker. | April 19, 2023
A U.S. appeals court on Tuesday said it will accelerate reviewing Illumina Inc's challenge to a federal agency order requiring the biotechnology company to divest cancer diagnostic test maker Grail LLC.
By Mike Scarcella (Reuters) - A U.S. appeals court on Tuesday said it will accelerate reviewing Illumina Inc's challenge to a federal agency order req.
/PRNewswire/ Latham & Watkins LLP1 is pleased to announce that Makan Delrahim, former Assistant Attorney General (AAG) in the U.S. Department of Justice.